Debate #2: Drugs that have not received regulatory approvals in sarcomas should not be used to treat sarcoma patients except on a clinical trial

Moderator(s)

• 

  Mark A. Dickson, MD

  Associate Attending Physician
  MSKCC
  new york, New York, United States

Presenter(s)

• 

  Robin L. Jones, BSc, MB BS, MRCP, MD

  Consultant Medical Oncologist
  Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
  London, England, United Kingdom
• 

  Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his)

  Clinical Associate Professor
  The Chinese University of Hong Kong
  Hong Kong, Hong Kong

  Slides